Log in to save to my catalogue

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4c95a22fa38048aeaa9f5cfd28ba10df

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

About this item

Full title

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

Publisher

England: BioMed Central Ltd

Journal title

Journal of translational medicine, 2020-01, Vol.18 (1), p.10-10, Article 10

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Predicting the clinical course of prostate cancer is challenging due to the wide biological spectrum of the disease. The objective of our study was to identify prostate cancer prognostic markers in patients 'sera using a multi-omics discovery platform.
Pre-surgical serum samples collected from a longitudinal, racially diverse, prostate cancer pa...

Alternative Titles

Full title

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4c95a22fa38048aeaa9f5cfd28ba10df

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4c95a22fa38048aeaa9f5cfd28ba10df

Other Identifiers

ISSN

1479-5876

E-ISSN

1479-5876

DOI

10.1186/s12967-019-02185-y

How to access this item